Clinical Trials Browser

Phase 2 × Plaque, Amyloid × 1 year × Clear all

NCT05907954 2026-03-16

(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma

Phase 2 Active not recruiting

Uveal Melanoma, Plaque, Amyloid